All In Biotech

Free tool

FAERS Monitor: Cipro Hc

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020805 or its brand name (Cipro Hc, Ciprofloxacin Hydrochloride, Hydrocortisone). Reports on generic versions are filed under their own applications.

Reports

20,745

Serious

13,575

65% of reports

Hospitalization

6,047

Death reported

1,437

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug hypersensitivity2,484
  • pain1,607
  • neuropathy peripheral1,445
  • nausea1,413
  • diarrhoea1,408
  • arthralgia1,388
  • fatigue1,329
  • urinary tract infection1,024
  • dyspnoea991
  • pain in extremity986
  • headache985
  • drug ineffective926
  • anxiety906
  • asthenia892
  • dizziness860

Reports by year received

View as table
YearReports
2004331
2005401
2006457
2007319
2008792
2009659
2010710
2011685
2012622
20131,034
20141,211
20151,694
20162,846
20171,533
20181,484
20191,842
20201,248
2021870
2022532
2023476
2024380
2025404
2026215

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,414 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neuropathy peripheralSignal1,44515.614.919,552
drug hypersensitivitySignal2,48413.212.727,821
urinary tract infectionSignal1,0246.15.84,388
pain in extremitySignal9863.43.21,687
arthralgiaSignal1,3883.43.22,379
anxietySignal9063.23.01,411
painSignal1,6072.72.51,704
astheniaSignal8922.42.3745
diarrhoeaSignal1,4082.22.1964
nausea1,4131.81.7532
dyspnoea9911.81.7344
dizziness8601.71.6282
fatigue1,3291.71.6425
headache9851.61.5224
drug ineffective9260.70.7115

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.